172 related articles for article (PubMed ID: 30536843)
1. Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1.
Song C; Xiong Y; Liao W; Meng L; Yang S
J Cell Physiol; 2019 Aug; 234(8):12910-12917. PubMed ID: 30536843
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1.
Zhang GD; Gai PZ; Liao GY; Li Y
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
6. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of APC expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract][Full Text] [Related]
9. Potential Effects of Metformin on the Vitality, Invasion, and Migration of Human Vascular Smooth Muscle Cells via Downregulating lncRNA-ATB.
Jia W; Zhou Y; Sun L; Liu J; Cheng Z; Zhao S
Dis Markers; 2022; 2022():7480199. PubMed ID: 35027983
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1.
Hu B; Shi G; Li Q; Li W; Zhou H
J Cell Biochem; 2019 Apr; 120(4):6330-6338. PubMed ID: 30362292
[TBL] [Abstract][Full Text] [Related]
11. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
[TBL] [Abstract][Full Text] [Related]
12. lncRNA ROR promotes the proliferation of renal cancer and is negatively associated with favorable prognosis.
Shi J; Zhang W; Tian H; Zhang Q; Men T
Mol Med Rep; 2017 Dec; 16(6):9561-9566. PubMed ID: 29039528
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-ATB Promotes Lung Squamous Carcinoma Cell Proliferation, Migration, and Invasion by Targeting microRNA-590-5p/NF90 Axis.
Li J; Xia R; Liu T; Cai X; Geng G
DNA Cell Biol; 2020 Mar; 39(3):459-473. PubMed ID: 31934791
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB.
Li Y; Ye Y; Chen H
Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
[TBL] [Abstract][Full Text] [Related]
16. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC00467 Promotes Glioma Progression through Inhibiting P53 Expression via Binding to DNMT1.
Zhang Y; Jiang X; Wu Z; Hu D; Jia J; Guo J; Tang T; Yao J; Liu H; Tang H
J Cancer; 2020; 11(10):2935-2944. PubMed ID: 32226508
[No Abstract] [Full Text] [Related]
19. High expression of long non-coding RNA ATB is associated with poor prognosis in patients with renal cell carcinoma.
Qi JJ; Liu YX; Lin L
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2835-2839. PubMed ID: 28682434
[TBL] [Abstract][Full Text] [Related]
20. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.
Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z
J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
